Follow
Adam C Parslow
Adam C Parslow
Baker Heart and Diabetes Institute
Verified email at baker.edu.au - Homepage
Title
Cited by
Cited by
Year
Sample Drift Correction Following 4D Confocal Time-lapse Imaging
A Parslow, A Cardona, RJ Bryson-Richardson
JoVE (Journal of Visualized Experiments), e51086-e51086, 2014
1332014
Antibody–Drug Conjugates for Cancer Therapy
AC Parslow, S Parakh, FT Lee, HK Gan, AM Scott
Biomedicines 4 (3), 14, 2016
872016
Evolution of anti-HER2 therapies for cancer treatment
S Parakh, HK Gan, AC Parslow, IJG Burvenich, AW Burgess, AM Scott
Cancer Treatment Reviews, 2017
802017
The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma
R Coulson, SH Liew, AA Connelly, NS Yee, S Deb, B Kumar, AC Vargas, ...
Oncotarget 8 (12), 18640-18656, 2017
622017
Autophagy Induction Is a Tor-and Tp53-Independent Cell Survival Response in a Zebrafish Model of Disrupted Ribosome Biogenesis
Y Boglev, AP Badrock, AJ Trotter, Q Du, EJ Richardson, AC Parslow, ...
PLoS genetics 9 (2), e1003279, 2013
622013
Zebrafish models for nemaline myopathy reveal a spectrum of nemaline bodies contributing to reduced muscle function
TE Sztal, M Zhao, C Williams, V Oorschot, AC Parslow, A Giousoh, ...
Acta neuropathologica 130 (3), 389-406, 2015
482015
Abnormal nuclear pore formation triggers apoptosis in the intestinal epithelium of elys-deficient zebrafish
TA de Jong–Curtain, AC Parslow, AJ Trotter, NE Hall, H Verkade, ...
Gastroenterology 136 (3), 902-911. e7, 2009
442009
Antibody-mediated delivery of therapeutics for cancer therapy
S Parakh, AC Parslow, HK Gan, AM Scott
Expert opinion on drug delivery 13 (3), 401-419, 2016
392016
Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth
P Thilakasiri, J Huynh, AR Poh, CW Tan, TL Nero, K Tran, AC Parslow, ...
EMBO molecular medicine 11 (4), 2019
282019
Receptor occupancy imaging studies in oncology drug development
IJG Burvenich, S Parakh, AC Parslow, ST Lee, HK Gan, AM Scott
The AAPS journal 20 (2), 1-16, 2018
132018
In vitro and in vivo evaluation of 89Zr-DS-8273a as a Theranostic for anti-death receptor 5 therapy
IJG Burvenich, FT Lee, N Guo, HK Gan, A Rigopoulos, AC Parslow, ...
Theranostics 6 (12), 2225, 2016
112016
Morphological Analysis of the Zebrafish Digestive System
AJ Trotter, AC Parslow, JK Heath
Zebrafish: Methods and Protocols, 289-315, 2009
112009
New insights into ErbB3 function and therapeutic targeting in cancer
U Hafeez, AC Parslow, HK Gan, AM Scott
Expert Review of Anticancer Therapy 20 (12), 1057-1074, 2020
102020
The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile
J Berthelet, VC Wimmer, HJ Whitfield, A Serrano, T Boudier, S Mangiola, ...
Science Advances 7 (28), 2021
92021
Host IL-11 signaling suppresses CD4+ T cell-mediated anti-tumor responses to colon cancer in mice
J Huynh, D Baloyan, D Chisanga, W Shi, M O'Brien, S Afshar-Sterle, ...
Cancer Immunology Research, 2021
72021
The angiotensin receptor blocker, losartan, inhibits mammary tumor development and progression to invasive carcinoma. Oncotarget. 2017; 8 (12): 18640-56
R Coulson, SH Liew, AA Connelly, NS Yee, S Deb, B Kumar, AC Vargas, ...
7
Genome-wide identification of conserved intronic non-coding sequences using a Bayesian segmentation approach
M Algama, E Tasker, C Williams, AC Parslow, RJ Bryson-Richardson, ...
BMC genomics 18 (1), 1-14, 2017
52017
Confocal Microscopy Reveals Cell Surface Receptor Aggregation Through Image Correlation Spectroscopy
AC Parslow, AHA Clayton, P Lock, AM Scott
JoVE (Journal of Visualized Experiments), e57164, 2018
42018
Determination of mRNA and protein expression patterns in zebrafish
EL Christie, AC Parslow, JK Heath
Wnt Signaling, 253-272, 2009
22009
A protocol for rapid and parallel isolation of myocytes and non-myocytes from multiple mouse hearts
GE Farrugia, MA McLellan, KL Weeks, A Matsumoto, CD Cohen, ...
STAR protocols 2 (4), 100866, 2021
12021
The system can't perform the operation now. Try again later.
Articles 1–20